The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Fortifying Cyber Shores: Fighting Against a Tsunami Of DDoS Attacks
Harish Kumar GS, Head of Sales, India and SAARC, Check Point Software Technologies A Distributed Denial of Service (DDoS) attack…
A Star-Studded Celebration: 15 Years of Majestic Pride, Goa
As the calendar turned its pages to January, the Majestic Pride completed 15 glorious years of entertainment, glamour, and unforgettable…
inDrive the official transporter for the 6th edition of Differently abled Celebration
inDrive, the prominent ride-hailing app in Egypt, signed a protocol with a Differently Abled representative marking inDrive’s role as the…